Esperion Reveals Patent Settlement Agreement With Hetero USA For Cholestrol Drug Nexletol
2/6 15:18
(RTTNews) - Esperion Therapeutics, Inc. (ESPR), a commercial stage biopharma company, on Monday announced a patent litigation settlement agreement with Hetero USA, Inc. and its affiliates Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, and Honour Lab Ltd. As per the agreement, Hetero...